Filing Details
- Accession Number:
- 0001209191-22-032618
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-27 17:01:52
- Reporting Period:
- 2022-05-25
- Accepted Time:
- 2022-05-27 17:01:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604477 | Sqz Biotechnologies Co | SQZ | Biological Products, (No Disgnostic Substances) (2836) | 462431115 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829257 | F. Klavs Jensen | 200 Arsenal Yards Blvd, Suite 210 Watertown MA 02472 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-25 | 14,326 | $3.52 | 353,309 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.48 to $3.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Includes 1 share of common stock inadvertently omitted from the amount reported in Columns 4 and 5 of the Form 4 filed by the Reporting Person on November 3, 2020 as a result of an error in calculating the aggregation of fractional shares resulting from conversion.
Billionaire Hedge Funds
